Sign Up Today and Learn More About CytoVale Stock
Invest in or calculate the value of your shares in CytoVale or other pre-IPO companies through EquityZen's platform.
CytoVale Stock (CYTV)
CytoVale is a medical technology company that focuses on advancing early detection technologies to diagnose immune-mediated diseases.
About CytoVale Stock
Founded
2013
Headquarters
San Francisco, CA, US
Industries
Software, Artificial Intelligence, Data and Analytics
CytoVale Press Mentions
Stay in the know about the latest news on CytoVale
Cytovale Appoints Eric Khairy as Chief Marketing Officer
prnewswire • Apr 07, 2026
Peer-Reviewed Study Shows IntelliSep Influences ED Physicians' Sepsis Diagnostic Decisions
prnewswire • Mar 31, 2026
Multicenter Study Shows Reproducible Clinical and Operational Gains Following Expansion of IntelliSep Sepsis Test Across Health System
prnewswire • Mar 23, 2026
Cytovale's IntelliSep® Named Modern Healthcare's Best in Business for Second Consecutive Year
prnewswire • Jan 12, 2026
Rapid Sepsis Test Enables Hospital to Reduce Mortality by 42% and Shorten Hospital Stay by Two Days, According to Academic Medical Center Study
prnewswire • Dec 10, 2025
CytoVale Management
Leadership team at CytoVale
Co-Founder, CEO
Ajay Shah
Co-founder and Board Member
Dino Di Carlo
Join now and verify your accreditation status to gain access to:
- CytoVale Current Valuation
- CytoVale Stock Price
- CytoVale Management
- Available deals in CytoVale and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- CytoVale Cap Table and Funding History by Share Class and Liquidity Preferences
- CytoVale Revenue and Financials
- CytoVale Highlights
- CytoVale Business Model
- CytoVale Risk Factors
- CytoVale Research Report from SACRA Research
Trading CytoVale Stock
How to invest in CytoVale stock?
Accredited investors can buy pre-IPO stock in companies like CytoVale through EquityZen funds. These investments are made available by existing CytoVale shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell CytoVale stock?
Shareholders can sell their CytoVale stock through EquityZen's private company marketplace. EquityZen's network includes over 440K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 52K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
